Victor B. Talisa

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Doubly Robust Targeted Estimation of Conditional Average Treatment Effects for Time-to-event Outcomes with Competing Risks	2024	Runjia Li Victor B. Talisa Chung‐Chou H. Chang
+ PDF Chat	Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity	2024	Zhongying Xu Tianzhou Ma Lu Tang Victor B. Talisa Chung‐Chou H. Chang
+	1191: HETEROGENEITY IN RESPONSE TO EARLY GOAL-DIRECTED THERAPY IN SEPSIS	2022	Victor B. Talisa Faraaz Shah Chung‐Chou H. Chang Christopher Seymour Lu Tang Jason Kennedy Sofia Triantafyllou Gregory S. Cooper Kimberley M. DeMerle Florian Mayr
+	Reply to Wirth et al	2022	Victor B. Talisa Florian Mayr Adeel A. Butt
+	Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity	2022	Zhongying Xu Andriy I. Bandos Tianzhou Ma Lu Tang Victor B. Talisa Chung‐Chou H. Chang
+	Learning and confirming a class of treatment responders in clinical trials	2021	Victor B. Talisa Chung‐Chou H. Chang
+	Novel statistical approaches for practical problems in individualized medicine	2021	Victor B. Talisa
+	Estimating individual-level average treatment effects: Challenges, modeling approaches, and practical applications	2020	Victor B. Talisa Chung‐Chou H. Chang
+	A Novel Ensemble Learning Approach to Understand Heterogeneity of Treatment Effect in Critical Care Trials	2020	Faraaz Shah Victor B. Talisa Derek C. Angus Jason Kennedy Kimberley M. DeMerle Christopher Seymour Chia‐Che Chang Sachin Yende
+ PDF Chat	Arguing for Adaptive Clinical Trials in Sepsis	2018	Victor B. Talisa Sachin Yende Christopher Seymour Derek C. Angus

Common Coauthors

Coauthor	Papers Together
Chung‐Chou H. Chang	6
Derek C. Angus	3
Christopher Seymour	3
Sachin Yende	3
Jason Kennedy	2
Lu Tang	2
Faraaz Shah	2
Florian Mayr	2
Kimberley M. DeMerle	2
Gregory S. Cooper	1
Sandra Peake	1
Paul Mouncey	1
Tianzhou Ma	1
Alisa M. Higgins	1
Adeel A. Butt	1
Kathy Rowan	1
Zhongying Xu	1
Tianzhou Ma	1
Donald M. Yealy	1
Rinoldo Bellomo	1
Runjia Li	1
Zhongying Xu	1
Sofia Triantafyllou	1
David A Harrison	1
Lu Tang	1
Andriy I. Bandos	1
Chia‐Che Chang	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Estimating causal effects of treatments in randomized and nonrandomized studies.	1974	Donald B. Rubin	2
+ PDF Chat	Effectively Selecting a Target Population for a Future Comparative Study	2013	Lihui Zhao Lü Tian Tianxi Cai Brian Claggett L. J. Wei	2
+	Recursive partitioning for heterogeneous causal effects	2016	Susan Athey Guido W. Imbens	2
+ PDF Chat	Some methods for heterogeneous treatment effect estimation in high dimensions	2018	Scott Powers Junyang Qian Kenneth Jung Alejandro Schuler Nigam H. Shah Trevor Hastie Robert Tibshirani	2
+ PDF Chat	Generalized random forests	2019	Susan Athey Julie Tibshirani Stefan Wager	2
+ PDF Chat	Subgroup identification from randomized clinical trial data	2011	Jared C. Foster Jeremy M. G. Taylor Stephen J. Ruberg	2
+ PDF Chat	A Predictive Enrichment Procedure to Identify Potential Responders to a New Therapy for Randomized, Comparative Controlled Clinical Studies	2015	Junlong Li Lihui Zhao Lü Tian Tianxi Cai Brian Claggett Andrea Callegaro Benjamin Dizier Bart Spiessens Fernando Ulloa‐Montoya L. J. Wei	2
+ PDF Chat	Metalearners for estimating heterogeneous treatment effects using machine learning	2019	Sören R. Künzel Jasjeet S. Sekhon Peter J. Bickel Bin Yu	2
+ PDF Chat	The utility of Bayesian predictive probabilities for interim monitoring of clinical trials	2014	Benjamin R. Saville Jason T. Connor Gregory D. Ayers JoAnn Alvarez	1
+	Bayesian Approaches to Randomized Trials	1994	David J. Spiegelhalter Laurence S. Freedman Mahesh Parmar	1
+	Adaptive clinical trial designs in oncology.	2014	Yong Zang J. Jack Lee	1
+ PDF Chat	Model Selection for Estimating Treatment Effects	2013	Craig A. Rolling Yuhong Yang	1
+ PDF Chat	Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials	2004	Feifang Hu Zhang Li	1
+	Limitations of Applying Summary Results of Clinical Trials to Individual Patients	2007	David M. Kent Rodney A. Hayward	1
+	Causal Inference Using Potential Outcomes	2005	Donald B. Rubin	1
+	Discrete sequential boundaries for clinical trials	1983	K. K. Gordon Lan David L. DeMets	1
+ PDF Chat	A regression tree approach to identifying subgroups with differential treatment effects	2015	Wei‐Yin Loh Xu He Michael Man	1
+	Semiparametric Efficiency in Multivariate Regression Models with Missing Data	1995	James M. Robins Andrea Rotnitzky	1
+	Optimal Adaptive Designs for Binary Response Trials	2001	William F. Rosenberger Nigel Stallard Anastasia Ivanova Cherice N. Harper Michelle L. Ricks	1
+	Composite End Points in Randomized Trials	2010	George Tomlinson Allan S. Detsky	1
+ PDF Chat	Consistency of cross validation for comparing regression procedures	2007	Yuhong Yang	1
+	Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images	1984	Stuart Geman Donald Geman	1
+	Adaptive clinical trials in oncology	2011	Donald A. Berry	1
+ PDF Chat	Central Limit Theorems for Doubly Adaptive Biased Coin Designs	1995	Jeffrey R. Eisele Michael Woodroofe	1
+	I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy	2009	AD Barker C C Sigman Kelloff Gj NM Hylton DA Berry L. Esserman	1
+	ON THE LIKELIHOOD THAT ONE UNKNOWN PROBABILITY EXCEEDS ANOTHER IN VIEW OF THE EVIDENCE OF TWO SAMPLES	1933	W. R THOMPSON	1
+ PDF Chat	Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials	2007	Ignacio Ferreira‐González Gaiet Permanyer-Miralda Antònia Domingo‐Salvany Jason W. Busse Diane Heels‐Ansdell Víctor M. Montori Elie A. Akl Dianne Bryant Pablo Alonso‐Coello Jordi Alonso	1
+ PDF Chat	Model-Based Recursive Partitioning	2008	Achim Zeileis Torsten Hothorn Kurt Hornik	1
+	Estimating treatment effect heterogeneity in randomized program evaluation	2013	Kosuke Imai Marc Ratkovic	1
+	A Multiple Testing Procedure for Clinical Trials	1979	Peter C. O’Brien Thomas R. Fleming	1
+ PDF Chat	Population heterogeneity and causal inference	2013	Yu Xie	1
+	A step-down multiple hypotheses testing procedure that controls the false discovery rate under independence	1999	Yoav Benjamini Wei Liu	1
+	Strategies for Identifying Predictive Biomarkers and Subgroups with Enhanced Treatment Effect in Clinical Trials Using SIDES	2014	Ilya Lipkovich Alex Dmitrienko	1
+	Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests	2000	James M. Robins Dianne M. Finkelstein	1
+	The impact of high-risk patients on the results of clinical trials	1997	John P.A. Ioannidis Joseph Lau	1
+	The Platform Trial	2015	Scott Berry Jason T. Connor Roger Lewis	1
+	Bayesian clinical trials	2006	Donald A. Berry	1
+ PDF Chat	The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities	2011	SJ Pocock Cono Ariti Timothy Collier Dee Dee Wang	1
+ PDF Chat	Assessing Treatment‐Selection Markers using a Potential Outcomes Framework	2012	Ying Huang Peter B. Gilbert Holly Janes	1
+	Assignment to Treatment Group on the Basis of a Covariate	1977	Donald B. Rubin	1
+ PDF Chat	Adaptive enrichment designs for clinical trials	2013	Noah Simon Richard H. Simon	1
+	Group sequential methods in the design and analysis of clinical trials	1977	Stuart J. Pocock	1
+	Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations	2011	Ilya Lipkovich Alex Dmitrienko Jonathan Denne Gregory G. Enas	1
+	Bayesian Nonparametric Modeling for Causal Inference	2010	Jennifer Hill	1
+ PDF Chat	Bayesian Adaptive Randomized Trial Design for Patients With Recurrent Glioblastoma	2012	Lorenzo Trippa Eudocia Q. Lee Patrick Y. Wen Tracy T. Batchelor Timothy F. Cloughesy Giovanni Parmigiani Brian M. Alexander	1
+ PDF Chat	A Simple Method for Estimating Interactions Between a Treatment and a Large Number of Covariates	2014	Lü Tian Ash A. Alizadeh Andrew J. Gentles Robert Tibshirani	1
+ PDF Chat	Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials	2015	Lorenzo Trippa Patrick Y. Wen Giovanni Parmigiani Donald A. Berry Brian M. Alexander	1
+	Subgroup Analysis via Recursive Partitioning	2009	Xiaogang Su Chih‐Ling Tsai Hansheng Wang David M. Nickerson Bogong Li	1
+ PDF Chat	Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia	1995	James Shepherd Stuart M. Cobbe Ian Ford Christopher Isles A R Lorimer Peter W. Macfarlane James H. McKillop Christopher J. Packard	1
+	The Randomized Play-the-Winner Rule in Medical Trials	1978	L. J. Wei S. D. Durham	1